Quick Answer
SYNAPTICS Inc reported Diluted EPS of $1.22 per share (loss) for fiscal year 2025.
SYNAPTICS Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.22 | -138.6% |
| 2024 | $3.16 | +72.7% |
| 2023 | $1.83 | -71.1% |
| 2022 | $6.33 | +204.3% |
| 2021 | $2.08 | -39.0% |
| 2020 | $3.41 | +616.7% |
| 2019 | -$0.66 | +81.8% |
| 2018 | -$3.63 | -365.0% |
| 2017 | $1.37 | -28.3% |
| 2016 | $1.91 | -32.7% |
| 2015 | $2.84 | +125.4% |
| 2014 | $1.26 | -56.4% |
| 2013 | $2.89 | +84.1% |
| 2012 | $1.57 | -12.8% |
| 2011 | $1.80 | +20.0% |
| 2010 | $1.50 | +11.1% |
| 2009 | $1.35 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.38 | -860.0% | +28.3% |
| September 30, 2025 | -$0.53 | +8.6% | +5.4% |
| March 31, 2025 | -$0.56 | -21.7% | -1220.0% |
| December 31, 2024 | $0.05 | +121.7% | +108.6% |
| September 30, 2024 | -$0.58 | +59.4% | -26.1% |
| March 31, 2024 | -$0.46 | -276.9% | -100.0% |
| December 31, 2023 | -$0.23 | -141.8% | +83.9% |
| September 30, 2023 | -$1.43 | -189.9% | -650.0% |
- SYNAPTICS Inc showed a decrease of -138.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, SYNAPTICS Inc’s diluted eps has declined by 190.4% (from $1.35 per share to $1.22 per share (loss)).
- The most recent figure is from SYNAPTICS Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: